Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE HUMAN FIBRIN GLUE (HFG) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PACKAGE FORM LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 INDUSTRY INSIGHTS
6 REGULATORY ANALYSIS
6.1.1 REGULATION IN U.S.
6.1.2 REGULATION IN EUROPE
6.1.3 REGULATION IN AUSTRALIA
6.1.4 REGULATION IN CANADA
6.1.5 REGULATION IN CHINA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASE IN TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASING SURGICAL PROCEDURES
7.1.3 ADVANTAGES OF HUMAN FIBRIN GLUE
7.1.4 INCREASE IN THE GERIATRIC POPULATION
7.1.5 SUPERIORITY OF FIBRIN SEALANTS, OVER LIMITATIONS OF CONVENTIONAL METHODS
7.2 RESTRAINTS
7.2.1 STRINGENT RULES & REGULATORY
7.2.2 HIGH COST OF PRODUCTS
7.2.3 RISK OF VIRAL INFECTIONS
7.3 OPPORTUNITIES
7.3.1 INCREASE IN PREVALENCE OF CHRONIC DISORDERS
7.3.2 RISE IN MINIMALLY INVASIVE SURGERIES
7.3.3 RISING PLASTIC SURGERIES
7.4 CHALLENGES
7.4.1 COMPLICATION RELATED TO USE OF HUMAN FIBRIN GLUE
7.4.2 LACK OF SKILLED PROFESSIONALS
7.4.3 DECREASED SURGICAL PROCEDURES DUE TO COVID-19
8 IMPACT OF COVID-19 ON EUROPE HUMAN FIBRIN GLUE (HFG) MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON SUPPLY CHAIN
8.3 IMPACT ON DEMAND
8.4 CONCLUSION
9 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM
9.1 OVERVIEW
9.2 LIQUID
9.2.1 1-2 ML
9.2.2 7-10 ML
9.2.3 3-4 ML
9.2.4 5-6 ML
9.3 PATCH
9.4 OTHERS
10 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 SPECIALTY CLINICS
10.4 AMBULATORY CARE CENTER
10.5 OTHERS
11 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 WOUND MANAGEMENT
12.3 BURN BLEEDING
12.4 PLASTIC SURGERY
12.5 GENERAL SURGERY
12.6 VASCULAR SURGERIES
12.7 LACERATIONS OF LIVER AND SPLEEN
12.8 CARDIAC SURGERY
12.9 PULMONARY SURGERY
12.1 ORTHOPEDIC SURGERIES
12.11 NEUROSURGERY
12.12 OTHERS
13 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION
13.1 EUROPE
13.1.1 GERMANY
13.1.2 U.K.
13.1.3 FRANCE
13.1.4 ITALY
13.1.5 SPAIN
13.1.6 SWITZERLAND
13.1.7 RUSSIA
13.1.8 NETHERLANDS
13.1.9 TURKEY
13.1.10 BELGIUM
13.1.11 REST OF EUROPE
14 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: EUROPE
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 CSL LIMITED
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 JOHNSON & JOHNSON SERVICES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 BAXTER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 HUALAN BIOLOGICAL ENGINEERING, ING
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 SHANGHAI RAAS
16.5.1 COMPANY SNAPSHOT
16.5.2 COMPANY SHARE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 CORZA HEALTH
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENT
16.7 MARQUEE BIOSURGICAL
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENT
17 QUESTIONNAIRE
18 RELATED REPORTS
List of Table
TABLE 1 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 2 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 4 EUROPE PATCH IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 EUROPE OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 6 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 7 EUROPE HOSPITALS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 8 EUROPE SPECIALTY CLINICS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 9 EUROPE AMBULATORY CARE CENTERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 10 EUROPE OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 11 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 12 EUROPE DIRECT TENDER IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 EUROPE RETAIL SALES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 15 EUROPE WOUND MANAGEMENT IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 EUROPE BURN BLEEDING IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 EUROPE PLASTIC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 EUROPE GENERAL SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 EUROPE VASCULAR SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 EUROPE LACERATIONS OF LIVER AND SPLEEN IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 EUROPE CARDIAC SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 EUROPE PULMONARY SURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 EUROPE ORTHOPEDIC SURGERIES IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 EUROPE NEUROSURGERY IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 EUROPE OTHERS IN HUMAN FIBRIN GLUE (HFG) MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 27 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 28 EUROPE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 29 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 30 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 31 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 33 GERMANY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 34 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 35 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 36 GERMANY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 37 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 38 U.K. LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 39 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 40 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 41 U.K. HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 42 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 43 FRANCE LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 44 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 45 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 46 FRANCE HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 47 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 48 ITALY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 49 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 50 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 51 ITALY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 52 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 53 SPAIN LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 54 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 55 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 56 SPAIN HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 57 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 58 SWITZERLAND LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 59 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 60 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 61 SWITZERLAND HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 62 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 63 RUSSIA LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 64 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 65 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 66 RUSSIA HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 67 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 68 NETHERLANDS LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 69 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 70 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 71 NETHERLANDS HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 72 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 73 TURKEY LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 74 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 75 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 76 TURKEY HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 77 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 78 BELGIUM LIQUID IN HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
TABLE 79 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 80 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY END USERS, 2020-2029 (USD MILLION)
TABLE 81 BELGIUM HUMAN FIBRIN GLUE (HFG) MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 82 REST OF EUROPE HUMAN FIBRIN GLUE (HFG) MARKET, BY PACKAGE FORM, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION
FIGURE 2 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: DROC ANALYSIS
FIGURE 4 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR HUMAN FIBRIN GLUES ARE EXPECTED TO DRIVE THE EUROPE HUMAN FIBRIN GLUE (HFG) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 LIQUID IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HUMAN FIBRIN GLUE (HFG) MARKET IN 2022 AND 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE HUMAN FIBRIN GLUE (HFG) MARKET
FIGURE 14 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2021
FIGURE 15 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, 2022-2029 (USD MILLION)
FIGURE 16 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, CAGR (2022-2029)
FIGURE 17 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY PACKAGE FORM, LIFELINE CURVE
FIGURE 18 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2021
FIGURE 19 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 20 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, CAGR (2022-2029)
FIGURE 21 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY END USER, LIFELINE CURVE
FIGURE 22 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 23 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 24 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 25 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 26 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2021
FIGURE 27 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 28 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 29 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : SNAPSHOT (2021)
FIGURE 31 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021)
FIGURE 32 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2022 & 2029)
FIGURE 33 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY COUNTRY (2021 & 2029)
FIGURE 34 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET : BY PACKAGE FORM (2022-2029)
FIGURE 35 EUROPE HUMAN FIBRIN GLUE (HFG) MARKET: COMPANY SHARE 2021 (%)
